Website Worth Calculatorsiteprice.org domain valuewebsite worth domain value Website Worth Calculatorsiteprice.org domain valuewebsite worth domain value Help For Mood Disorders: 05.20

2020-05-20

A DREAM PROTEIN

      DYNORPHINS

   
      University of Toronto scientist Michael Salter and his team and scientist Josef Penninger from the Amgen Institute have explored a gene that carries information about the DREAM (downstream regulatory element antagonistic modulator) protein. DREAM protein is known to inhibit the production of dinorphins, one of the endorphins known as the hormone of happiness.
     These natural albumin have pain relief effects. Scientists have produced mutant mice without the DREAM gene. These mice produced more dinorphins and became less susceptible to pain. Salter said that mice felt all sorts of pain, less in all kinds of tissues, and neuropathic pain caused by the destruction of the nerves that could not be prevented until today. Stating that the information they obtained in the study is very different from the results of the studies on pain treatment, Salter noted that pain therapy research is based on morphine and mimics the endorphine of morphine.
      Salter emphasized that with the discovery of the DREAM gene, a completely new angle has emerged in the treatment of pain, after which treatment methods will be sought to block the DREAM gene or protein and thereby promote dinorphine production. Scientists reported that mice that did not feel pain seemed to be extremely healthy, physically or psychologically, unlike morphine and opiate pain relievers, mice did not become dependent on the endorphins they produce above normal.

2020-05-06

PYY,PP AND ENKEPHALIN

      PEPTIDE YY AND PANCREATIC POLYPEPTIDE

      Many patients with major depression refer a decreased appetite and weight loss among their symptoms. Peptide YY (PYY) and ghrelin belong to the family of peptides of the gut-brain axis implicated in the regulation of appetite and energy metabolism. PYY stimulates a powerful central satiety response and ghrelin increases food intake and weight gain. Brain-derived neurotrophic factor (BDNF) also contributes to the central control of food intake as an anorexigenic factor.
      The NPY system protects against distinct behavioural disturbances caused by peripheral immune challenge, ameliorating the acute sickness response and preventing long-term depression.
     In addition, pancreatic polypeptide PP and PYY signal to the brain to attenuate food intake, anxiety and depression-related behaviour.

ENKEPHALIN

      According to current research, this hormone causes presynaptic and postsynaptic inhibition in two pain-transmitting fibers: group C and group A. Like drug drugs, encephalin decreases the sodium permeability of the brain and prevents the activity of neurons.
      This creates a long-term change in the metabolism of our cells. It does this as follows:
- It changes the activation and deactivation forms of some genes in the nucleus of the cell.
- It affects the amount of inhibitors or stimulants.

Effects on the central nervous system
This hormone also affects the central nervous system in several ways:

Painkiller.
Euphoria.
Myosis.
Prevent cough reflex.
Nausea and vomiting.
Palpitations (if at high doses).

"Neuropeptides" (Calming Brain Molecules)


   


In the past, the brain was compared to the computer in terms of how it works. When neurons are not stimulated, there is no information flow, and when they are fired, a single messenger secretes molecules and stimulates the other cell. Accordingly, the working principle of the brain was thought to be like the "0" or "1" system in computers. For many years, it was thought that the molecules in the brain that communicate between cells are just "neurotransmitters". It has been understood in recent years that things have not been so simple, that electrical stimulation and brain control in neurons are not only through “neurotransmitters”.

      Brain research in the past 30 years has revealed the presence of other communication molecules. One of the most important developments is the discovery of molecules called "neuropeptides". The researchers first found regions on the surface of brain cells where morphine-like molecules bind. These are called "opiate" receivers. Strong painkillers like morphine show their effects by adhering to these opiate receptors. Later studies showed that morphine-like substances are secreted in the brain. These large protein molecules, consisting of long amino acid chains, were called "neuropeptides". The first discovered neuropeptide is “encephalin”, which means “inside your head”. “Endorphine”, which is found shortly after encephalins, is a morphine-like substance. "Dinorphine" is the one with the strongest effect among neuropeptides.

      Depending on the different subgroups of all these neuropeptides, there are many variants of encephalin or dinorphine. Each molecule has a different function according to the arrangement of the amino acids in its structure. For example, one type of endorphins relieves pain while the other reduces stress; another is strengthening memory. Although more than twenty "neuropeptide" varieties have been discovered yet, their number is thought to be hundreds. Considering that the secretion of these neuropeptides is also under the control of many enzymes, it appears that the brain functions are not only based on whether neurons send electrical impulses.

      Neuropeptides are the pain relieving, calming and enjoyable molecules of the brain. We like any incident, or the substances like food and beverage to us, thanks to the secretion of these morphine-like molecules. When we see a beautiful picture, listen to a nice melody or eat a delicious meal, molecules like endorphins, encephalin or dinorphins allow us to enjoy it by sticking to special receptors in neurons. The brain gets used to the feeling of pleasure created by these molecules that are secreted at certain intervals after a while. The body then tries to increase their level in the brain by consuming the substance that causes the secretion of neuropeptides, or by repeating the event. For example, the flavor that a delicious chocolate or hamburger leaves on the palate is actually due to increased levels of certain neuropeptides in the brain.

      In order to relive the pleasure of the secreted neuropeptides, the person wants to consume the same food again. This is thought to be one of the mechanisms underlying obesity, known as obesity. Endorphins or encephalins are the basis of many harmful substance and drug addictions. Neuropeptides do not only enjoy pleasure. They also have highly effective pain relief properties. Especially dinorphine can block the stimuli and pain that damage the brain.

      Pain relievers, such as morphine, which are usually used after surgery or to relieve the pain of cancer patients, also act by connecting to neuropeptide receptors in the brain. This is due to the increased number of endorphins and dinorphine receptors in the brain in cases of extreme pain. It is not a practical solution to use morphine or similar tranquilizers in all kinds of pain and stress; There are also several drawbacks. These brain-produced neuropeptides are usually sufficient to reduce pain and stress. In other words, the brain can produce its own painkiller and sedative.

     Neuropeptide Y is one of the systems that regulate stress flexibility. In cases of prolonged or recurrent stress, the neuropeptide Y is released from the key areas of the brain. This system works with different flexibility in individuals with different susceptibility to stress disorders. Of particular interest for gene-environment interactions is the exchange of genes that encode stress-sensitive signal molecules. This can contribute to stress predisposition or flexibility. The neuropeptide Y system also plays a key role in behavioral compliance with stress. Decreased neuropeptide Y level was also observed in treatment-resistant depression and post-traumatic stress disorder. The low neuropeptide Y expression or the neuropeptide Y system in response to stress are not functional enough and the resulting stress elasticity may increase susceptibility to stress related disorders.
     NPY
      Increases Appetite and Weight,
      Increases Blood Pressure,
      Reduces Sexual Power and
      It increases the risk of cancer by increasing angiogenesis
      Reduces Stress and Anxiety
      Relieves Pain
      Reduces Alcohol Consumption

 Neuropeptide S plasma levels, which have been shown to be anxiolytically effective in the central nervous system, are a diagnostic marker known to be associated with the severity of anxiety in Common Anxiety Disorder.

NEUROPHYSINS AND NEUROMEDIN U

NEUROPHYSIN I (NPI)

    In combination with oxytocin, it inhibits steroid production.Steroids also have some negative effects on mental health.
* Severe mood swings,
* Paranoia and delusion,
* Common sense of disturbance, Invincibility feelings,
* Madness and anger known as “Sharp anger” that can cause violence.
The hormone estrogen stimulates the production of oxytocin and its carrier, neurophysin 1.

NEUROPHYSIN II (NPII)
    The antidiuretic hormone (ADH or vasopressin) regulates the volume and osmolarity of urine through the kidneys, controls the water excretion and maintains the water balance without changing the homeostatic control and excretion of other substances.

    It is synthesized in neuroendocrine cells located in the supraoptic and paraventricular nuclei of the hypothalamus. The synthesized hormone is carried along the hypothalamo-pituitary tract due to the carrier protein called neurophysin-II and stored at the nerve endings in the neurohypophysis. When the supraoptic and paraventricular nuclei are stimulated for osmolarity or other reasons, the impulses move downwards, reaching the nerve endings and increasing membrane permeability to calcium ions.
    Stored in vesicles at the end of the nerve, ADH is released by exocytosis in response to an increase in calcium permeability. ADH and neurophysin are released together, but since they are loosely attached to each other, ADH is instantly separated from neurophysis. Neurophysis has no known function after leaving the nerve endings. The released ADH is carried to the systemic circulation by the neurohypophysis capillary circulation.

NEUROMEDIN U(NMU)

   NMU exerts its biological effects via two G protein-coupled receptors, NMUR1 and NMUR2. NMUR1 is mostly found in the periphery whereas NMUR2, the receptor of our interest, is most abundant in the central nervous system. The purpose of this study is to develop new peptidergic selective NMUR2 antagonists which are enzymatically stable and blood-brain-barrier (BBB) permeable.

   NMU-8, a natural occurring form of NMU, is taken as lead molecule for the synthesis of new analogues. The NMU-ligands are synthesized via solid phase peptide synthesis under classical conditions on rink amide polystyrene resin. A first batch of analogues is prepared on basis of the available structure-activity relationships. The in vitro characterization of these peptides is performed by an inositol phosphate accumulation assay.

   The results of this in vitro characterization are generally in line with the available literature. EC50 values of a similar magnitude are found for NMU-8. Moreover our experiments revealed that acetylation of the N-terminus leads in general to an increase of the relative activity compared to the non-acetylated ligand. In conclusion, further research is needed to synthesize a NMUR2 selective, enzymatically stable and BBB permeable ligand.(quote)